DNA and RNA extraction is a combination of chemical and physical processes involved in isolation of DNA or RNA.
Extraction kits simplify the process of extraction by eliminating the need for mechanical disruption and by decreasing hands-on time. Moreover, enhanced protocols for specific samples deliver reproducible purification of high quality DNA and RNA.
Due to the COVID-19 pandemic, the global DNA and RNA Extraction Kit market size is estimated to be worth US$ 1233 million in 2021 and is forecast to a readjusted size of US$ 2030.8 million by 2028 with a CAGR of 7.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe DNA and RNA Extraction Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe DNA and RNA Extraction Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
In the applications, Laboratories are the main places which consumed a larger part of DNA and RNA Extraction Kits, with 53.88% share of global market.
This report focuses on DNA and RNA Extraction Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall DNA and RNA Extraction Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and South Korea, etc.
Global DNA and RNA Extraction Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
DNA Extraction Kits
RNA Extraction Kits
Segment by Application
Hospital
Laboratory
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Qiagen
Thermo Fisher Scientific
Merck KGaA
Roche
Cytiva
Agilent
Danaher
Promega
Bio-Rad
Bioneer
Akonni Biosystems
Extraction kits simplify the process of extraction by eliminating the need for mechanical disruption and by decreasing hands-on time. Moreover, enhanced protocols for specific samples deliver reproducible purification of high quality DNA and RNA.
Due to the COVID-19 pandemic, the global DNA and RNA Extraction Kit market size is estimated to be worth US$ 1233 million in 2021 and is forecast to a readjusted size of US$ 2030.8 million by 2028 with a CAGR of 7.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe DNA and RNA Extraction Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe DNA and RNA Extraction Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
On the basis of product
type, DNA Extraction Kits represent a larger revenue share of the worldwide market, with 66.83% in 2019.In the applications, Laboratories are the main places which consumed a larger part of DNA and RNA Extraction Kits, with 53.88% share of global market.
This report focuses on DNA and RNA Extraction Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall DNA and RNA Extraction Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and South Korea, etc.
Global DNA and RNA Extraction Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
DNA Extraction Kits
RNA Extraction Kits
Segment by Application
Hospital
Laboratory
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Qiagen
Thermo Fisher Scientific
Merck KGaA
Roche
Cytiva
Agilent
Danaher
Promega
Bio-Rad
Bioneer
Akonni Biosystems
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.